Accueil › Lymphome de Burkitt › Ohio › Cincinnati
Essais cliniques pour Lymphome de Burkitt à Cincinnati, OH
12 études pour Lymphome de Burkitt recherchent des participants dans et autour de Cincinnati (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Recrutement en coursPhase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Recrutement en coursPhase 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · à 15 mi
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Recrutement en coursÉtude observationnelle
- Cincinnati Children's Hospital Medical Center, Cincinnati
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
Recrutement en coursPhase 2
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · à 15 mi
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Recrutement en coursPhase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Recrutement en coursPhase 3
- University of Cincinnati Medical Center, Cincinnati
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
Recrutement en coursPhase 3
- Cincinnati Children's Hospital Medical Center (Data Collection Only), Cincinnati
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Recrutement en coursPhase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Recrutement en coursPhase 3
- Cincinnati Children's Hospital Medical Center, Cincinnati
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Recrutement en coursPhase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL
Recrutement en coursPhase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
Recrutement en coursPhase 1
- University of Cincinnati, Cincinnati
Essais pour Lymphome de Burkitt dans d'autres villes
- Houston, TX21 études
- Milwaukee, WI16 études
- Philadelphia, PA16 études
- New York City, NY14 études
- Chicago, IL14 études
- Atlanta, GA12 études
- Seattle, WA11 études
- Boston, MA10 études
- Durham, NC10 études
- Aurora, CO10 études
- Los Angeles, CA10 études
- Kansas City, MO10 études
Autres études à Cincinnati
- Cancer du poumon non à petites cellules35 études
- Cancer (tous types)27 études
- Cancer du sein25 études
- Insuffisance cardiaque24 études
- Cancer colorectal21 études
- Leucémie aiguë myéloïde20 études
- Cancer métastatique20 études
- Cancer de l'ovaire19 études
- Cancer du poumon19 études
- Obésité19 études
- Cancer de la prostate18 études
- Myélome multiple17 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.